DNA damage response
Selected review and neurologic implications
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
An estimated 105 DNA lesions occur daily in the mammalian genome as a consequence of spontaneous decay, replication errors, and cell metabolism, including reactive oxygen species produced by the mitochondria. Oxidative stress is a major mechanism of DNA damage in the nervous system. Damaged DNA must be repaired to allow the proper reading of the genetic code. The response to DNA damage involves DNA damage recognition first, followed by resection of the affected site, DNA processing, filling the gap by action of DNA polymerases, and sealing of the nick by DNA ligases. Severe DNA damage also triggers chromatin remodeling, transient interruption of the cell cycle, and, if left unrepaired, programmed cell death. Whereas disturbances in DNA repair have been primarily linked to carcinogenesis or immunodeficiency, they can also affect development or survival of cells in the nervous system. A prototype neurologic disorder of DNA repair is ataxia telangiectasia (A-T) due to mutation of the A-T mutated (ATM) gene encoding A-T mutated (ATM), a kinase that coordinates responses to double-strand DNA breaks. Ataxia with oculomotor apraxia (AOA) results from mutations of key proteins involved in DNA end-processing and transcription regulation. Many neurodegenerative disorders are associated with inability to repair oxidative base modifications in both nuclear and mitochondrial DNA. Mismatch and base excision–repair are important modifiers in trinucleotide repeat expansion disorders. There are several reviews on the complex mechanisms involved in DNA repair1–7 and the neurologic disorders associated with defective DNA repair pathways.8–16 A comprehensive discussion of these is beyond the scope of this review and only selected topics are discussed here.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Fabricio Ferreira de Oliveira and Dr. Alan Cronemberger Andrade
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Ataxia-telangiectasia-like disorder in a family deficient for MRE11A, caused by a MRE11 variantMaryam Sedghi, Mehri Salari, Ali-Reza Moslemi et al.Neurology: Genetics, December 03, 2018 -
Articles
Risk of acute promyelocytic leukemia in multiple sclerosisCoding variants of DNA repair genesS.K. Hasan, F. Buttari, T. Ottone et al.Neurology, February 23, 2011 -
Basic Science in the Clinic
What Is the Role of the Cytosolic DNA Response in Neurodegeneration?Eduardo Benarroch et al.Neurology, May 17, 2021 -
Article
Confirming TDP2 mutation in spinocerebellar ataxia autosomal recessive 23 (SCAR23)Guido Zagnoli-Vieira, Francesco Bruni, Kyle Thompson et al.Neurology: Genetics, August 01, 2018